第 1 到 6 筆結果,共 6 筆。
公開日期 | 題名 | 作者 | 關聯 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2023 | Phytogalactolipids activate humoral immunity against colorectal cancer | Lin, H.-H; Wu, Y.-S.; Jian, T-Y.; Laio, J.-Y.; Chang, M.-T.; Shyur, L.-F. ; Lin, Y.-L. | Journal of Experimental & Clinical Cancer Research 42, 95 | |||
2 | 2023 | The critical role of galectin-12 in modulating lipid metabolism in sebaceous glands | Tsao, C.-H.; Hsieh, W.-C.; Lin, F.-J.; Yang, R.-Y.; Chang, M.-T.; Apaya, M. K.; Shyur, L.-F. ; Ke, L.-Y.; Zouboulis, C. C.; Liu, F.-T. | Journal of Investigative Dermatology 143(6), 913-924.e4 | |||
3 | 2022 | Phyto-sesquiterpene lactone derivatives are novel GPX4 inhibitors to combat vemurafenib resistant melanoma | Chang, M.-T.; Tsai, L.-C.; Nakagawa-Goto, K.; Lee, K.-H.; Shyur, L.-F. | ||||
4 | 2022 | Phyto-sesquiterpene lactone derivatives induce ferroptosis via GPX4 inhibition and metabolic reprogramming in BRAF inhibitor drug sensitive/resistant melanoma. | Chang, M.-T.; Tsai, L.-C.; Nakagawa-Goto, K.; Lee, K.-H.; Shyur, L.-F. | ||||
5 | 2022 | Phyto-sesquiterpene lactones DET and DETD-35 induce ferroptosis in vemurafenib sensitive and resistant melanoma via GPX4 inhibition and metabolic reprogramming. The 21th | Chang, M.-T.; Tsai, L.-C.; Nakagawa-Goto, K.; Lee, K.-H.; Shyur, L.-F. | ||||
6 | 2020 | Association of Arachidonic Acid-derived Lipid Mediators with Subsequent Onset of Acute Myocardial Infarction in Patients with Coronary Artery Disease | Huang, C.-C.; Chang, M.-T.; Leu, H.-B.; Yin, W.-H.; Tseng, W.-K.; Wu, Y.-W.; Lin, T.-H.; Yeh, H.-I; Chang, K.-C.; Wang, J.-H.; Wu, C.-C.; Shyur, L.-F. ; Chen, J.-W. | SCIENTIFIC REPORTS 10, 8105 |